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Abstract
Background: Delirium is common in older hospitalized patients. It has serious consequences e.g., poor health
outcomes, mortality and increased costs. Despite that, many cases are undetected. Early detection of delirium is
important in improving outcomes and use of assessment tools improves detection rates. The 4AT is a brief
screening tool for delirium detection, which has not previously been translated into Swedish. The study aim was to
evaluate diagnostic accuracy and clinical applicability of a Swedish version of the screening tool 4AT for delirium
detection.
Method: This diagnostic test accuracy study used a quantitative and a qualitative approach and evaluated the
patients’ and the health care professionals’ experiences of the tool. Study included 200 patients ≥65 years from a
university hospital and a county hospital in two Swedish regions. Medical specialties were geriatric stroke/
neurology, geriatric multimorbidity, severe cognitive impairment, orthopaedic, and urology. The translated 4AT was
tested against the reference standard DSM-IV-TR criteria, based on the Organic Brain Syndrome scale and patient
records. The 4AT was assessed simultaneously and independently by two assessors. Additionally, data was collected
through patient record reviews, and questions about applicability to the patients (n = 200) and the assessors (n =
37). Statistical analyses, and qualitative content analyses were conducted.
Results: By reference standard 18% had delirium, and by 4AT 19%. The overall percent agreement was 88%,
AUROC 0.808, sensitivity 0.70 (95% CI 0.51–0.84) and specificity 0.92 (95% CI 0.87–0.96). In the ward for severe
cognitive impairment (n = 63) the 4AT was less sensitive and less specific. In the other wards (n = 132) sensitivity
was 0.77 (95% CI 0.50–0.93), specificity 0.93 (95% CI 0.87–0.97), and AUROC 0.848. Interrater reliability (Kappa) was
0.918, p = < 0.001 (n = 144). The 4AT was well tolerated by patients, easy to use for health care professionals, and
took a few minutes to conduct.
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Conclusion: The Swedish version of 4AT is an accurate and applicable tool to use in clinical practice for detecting
delirium in hospitalized patients across different medical specialities, and to use by different professionals and levels
of seniority. To improve patient outcomes, we recommend the 4AT to be incorporated in clinical practice in health
care settings in Sweden.
Keywords: Applicability, 4AT, Delirium, Diagnostic accuracy, Qualitative content analysis, Validation study
Background
Delirium is a common acute and severe neuropsychiatric
disorder associated with a variety of adverse outcomes
[1]. Despite this, delirium is often underdiagnosed [1–6],
poorly understood and managed [1, 2, 5, 7], especially in
the most vulnerable and frail [5]. Adverse outcomes
caused by delirium include stressful experience, emo-
tional suffering and distress [8], complication of medical
conditions, prolonged hospital stays, increased mortality
[5], increased healthcare costs [9], and a great risk of de-
veloping dementia, especially in the oldest-old [10].
The highest incidence and prevalence of delirium
occur among older hospitalized patients and vary ac-
cording to patient group and type of care. In a meta-
analysis of 33 studies an overall prevalence of 23% was
found in older hospitalized patients [11]. Delirium and
cognitive impairment, e.g., dementia, are strongly inter-
twined. Cognitive impairment is the strongest risk factor
for delirium and delirium may trigger or worsen cogni-
tive impairment and preexisting dementia [5, 12, 13].
Additionally, one sign that manifests in delirium is cog-
nitive impairment, and delirium is often mistaken for de-
mentia although dementia undergoes a progressive
deterioration process [13]. Subtypes of delirium are
hyperactive, hypoactive, and mixed delirium [14]. In
most cases, delirium is triggered by treatable underlying
causes, e.g., acute illness [5, 14]. It is essential to prevent
delirium incidence due to its common occurrence and
association to poor outcomes [15]. The incidence might
be reduced in 30% [16] to 40% by providing good funda-
mental care, such as early mobilization and promotion
of sleep [2].
Delirium is a clinical bedside diagnosis, and knowledge
about the signs and symptoms of delirium, as well as rapid
detection of delirium, are required to prevent poor out-
comes [4, 17]. Despite this, about 70% of all cases of delir-
ium are unidentified in acute care hospitals [3, 5, 18, 19].
This is due to a lack of consensus, awareness and know-
ledge of delirium, as well as negative attitudes [20] and the
use of mainly subjective assessments with poor diagnostic
accuracy [3, 6, 7, 21]. To facilitate the process of identify-
ing delirium, the use of a brief bedside screening tool is
reasonable as a first stage, with a more detailed diagnosis
assessment of patients identified in the first stage [22]. An
internationally commonly used assessment tool for delir-
ium is the Confusion Assessment Method (CAM) [23]. To
use the tool correctly, regular training and separate testing
of cognitive function are required [23, 24], which makes
the CAM less feasible for routine use in acute care settings
[25, 26]. Three assessment tools for delirium are available
in Swedish, two of them developed in Sweden: the Or-
ganic Brain Syndrome scale (OBS scale) [27, 28] and the
Confusional State Evaluation (CSE) [29]. These tools are
relatively extensive, and mainly used in research. The third
instrument, the Swedish version of the Nursing Delirium
Screening Scale (NuDesc) [30], has shown low sensitivity
(47–66%). Moreover, regular training and separate cogni-
tive testing are recommended [31].
A brief screening tool developed and designed for the
detection of delirium in routine clinical practice is the
4AT (4 A’s test). The tool consists of the items Alert-
ness, Abbreviated Mental Test-4 (AMT4), Attention,
and Acute changes. The 4AT can be used by any health-
care professional at the first contact with the patient,
and at any other time when delirium is suspected [32].
The tool is an episodic tool, which means it is not de-
signed for daily monitoring multiple times per day or
daily use for prolonged periods, because of patient bur-
den and cognitive test practice effects [1]. Regular train-
ing is not required. Two existing brief tests for cognitive
function, the AMT4 and the Months Backwards test, are
incorporated in the 4AT to avoid separate cognitive test-
ing [32]. The 4AT acts as a screening tool and does not
provide a formal diagnosis. A score that indicates delir-
ium should thus trigger a more detailed assessment by a
suitably qualified professional [33]. In addition, the 4AT
has been used as a single tool for delirium detection
[34–36]. Several studies in different countries have
shown that the 4AT is a sensitive (76–93%) and specific
(70–94%) screening tool for delirium detection in geriat-
ric inpatients [22, 32, 33, 37]. The 4AT has so far not
been used in Sweden.
Although several assessment tools for delirium detec-
tion have been developed, few studies have evaluated the
clinical applicability of using these tools, either from the
perspective of patients or of healthcare professionals. Es-
sential for the success of clinical interventions is further
qualitative exploration of the use of diagnostic tools
[38]. In Sweden, the lack of validated brief screening
tools for delirium detection adapted to acute care hos-
pital settings may hamper early detection of delirium
and improvements in patient care and outcomes.
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Therefore, the aim of this study was to evaluate the diag-
nostic accuracy and clinical applicability of a Swedish
version of the 4AT screening tool for delirium detection.
Method
Design
This was a diagnostic test accuracy study with both a
quantitative and a qualitative approach. The study
followed the Standards for Reporting of Diagnostic Ac-
curacy Studies guidelines, the STARD, 2015 [39, 40].
Setting and sample
The study was conducted at a university hospital and a
county hospital. Specialist geriatric care is provided at
the university hospital but not specifically in the county
hospital. Patients were recruited consecutively from
wards with an expected high occurrence of patients with
delirium; in the university hospital from one geriatric
clinic including three non-surgical wards: geriatric
stroke/neurology*, geriatric multi-morbidity*, and severe
cognitive impairment, and in the county hospital from
two surgical wards: orthopedics* and urology* (*in this
study called general wards). The patients in the geriatric
wards for stroke/neurology and multimorbidity are
transferred from other wards because of the need of
additional geriatric care. The ward for severe cognitive
impairment is a specialist ward for patients with moder-
ate or severe dementia, or severe delirium where the pa-
tients are enrolled directly from the ED, from other
wards or electively. In the wards in the county hospital,
the patients are acutely as well as electively admitted.
The sample size was calculated to evaluate the concord-
ance between the 4AT and the reference standard. Assum-
ing that the area under the receiver operating characteristic
curve (AUROC) was 0.75 or higher (cutoff ≥4 for 4AT) and
that the occurrence of delirium was 20% [14] in the county
hospital, 65 patients were needed for 80% power and a 5%
significance level. For a significance level of 1%, 95 patients
were required. To compensate for potential dropouts, e.g.,
indeterminate diagnoses and subgroup analyses, 100 pa-
tients per hospital were included (n = 200). The inclusion
criteria were patients aged ≥65 years with admission to the
selected hospital wards the day before or on the same day
as the assessment, or within 24 h post-surgery. The exclu-
sion criteria were significant hearing or visual impairment,
terminal illness, coma, aphasia, and inability to understand
and answer questions in Swedish. In addition, the assessors
(n = 37) that conducted the assessments with the 4AT were
included in the applicability part of the study.
Measurements
Demographic and clinical data
The demographic and clinical data of the patients in-
cluded age, gender, admission type, length of hospital
stay, main diagnosis, dementia diagnosis, and coexisting
medical conditions, according to the International Statis-
tical Classification of Diseases and Related Health Prob-
lems - Tenth Revision (ICD-10) [41].
The demographic data of the assessors included gen-
der, profession, and the number of years of professional
experience and years at the current workplace.
Diagnostic accuracy
Index test The 4AT: The 4AT contains four items (sub-
scales). The first item assesses alertness by observation
(0; 4). Items 2–3 are existing tests for cognitive function:
the Abbreviated Mental Test-4 (AMT4), where the pa-
tients state their own age and date of birth, the present
location, and the current year (0–2), and the Months
Backwards test that assesses attention by asking the pa-
tient to name the months of the year in backward order
(0–2) [25, 32, 42, 43]. Item 4 evaluates significant acute
changes or a fluctuating course of alertness, cognition,
or other mental function, for instance, paranoia and hal-
lucinations developing over the past 2 weeks and still
evident in the last 24 h (0; 4). For this, information from
several sources may be required, e.g., from other profes-
sionals, next of kin, and patient records. The total score
ranges from 0 to 12, where 0 indicates that delirium or
severe cognitive impairment is unlikely; 1–3 indicates
possible cognitive impairment; and ≥ 4 indicates possible
delirium +/− cognitive impairment [32]. In this study, a
score < 4 indicated unlikely delirium, and ≥ 4 indicated
possible delirium, as defined by Shenkin et al. [33].
After obtaining approval from professor MacLullich
Edinburgh University, the translation process of the 4AT
followed a standard forward-backward translation pro-
cedure [44]. The 4AT (version 1.2) [45] was independ-
ently translated into Swedish by two of the authors (YJ,
EKS) and two persons skilled in English, one assistant
nurse experienced in delirium care and one research
manager. The different versions were discussed by the
four persons until consensus was reached. The Swedish
version was translated back into English by an independ-
ent bilingual translator who had no knowledge of the
original tool. There were a few discrepancies between
the back-translated version and the original English ver-
sion, and these discrepancies were discussed by the four
initial translators. Two of the authors (TT, NB), special-
ists in neuro-geriatric medicine and experienced in delir-
ium care, agreed on the final Swedish version.
Reference standard The criteria for delirium in the
Diagnostic and Statistical Manual on Mental Disorders,
4th ed. Text Revision (DSM-IV-TR) [46], was used as
the reference standard based on information derived
from the OBS scale [27, 28] and patient records.
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The OBS scale is an interview and observation scale
developed for clinical evaluation of various behavioral,
psychiatric and emotional symptoms and signs appear-
ing in organic brain disorders in older people, such as
dementia or delirium [28, 47]. This reference standard
procedure has previously been used in several Swedish
studies, e.g., Björkman Björkelund, 2006 [28], Edlund
et al., 2007 [48], Lingehall, 2017 [31], Smulter et al.,
2019 [6]. The OBS scale (score 0–165) is divided into
two parts. Part I, the disorientation subscale (score 0–
48), reflects a short-time perspective and comprises 16
questions about the patient’s awareness of and orienta-
tion to own identity, time and place, and knowledge
about some general topics. Part II, the confusion sub-
scale (score 0–117), evaluates the last 7 days, covering a
wide spectrum of psychopathology in 39 clinical items.
The subscale reflects the severity and variation of the
signs and symptoms of the clinical state, suspiciousness,
emotional reactions, language and speech difficulties, de-
lusions and hallucinations, neurological symptoms,
spatial orientation and recognition, physical and prac-
tical ability, and social interaction skills. No cutoff is
suggested. The items and their ratings are described in
detail in e.g., Björkman Björkelund et al. [28].
The DSM-IV-TR criteria for the diagnosis of delirium
are disturbance of consciousness (i.e., reduced clarity of
awareness of the environment) with reduced ability to
focus, sustain or shift attention, and disturbances in cog-
nition that develop over a short period of time and rep-
resent an acute change that tends to fluctuate in
severity. The disturbances are not better explained by
another preexisting cognitive disorder. Evidence is re-
quired that the disturbance is a direct physiological con-
sequence of another medical condition, substance
intoxication or withdrawal, or is due to multiple etiolo-
gies [46].
Clinical applicability
The time duration of the assessments with the 4AT and
the OBS scale was measured by the assessors in a sub-
sample of 100 patients (county hospital).
Experiences of the 4AT were evaluated from the pa-
tients’ and the assessors’ perspective in the two hospitals.
Open-ended questions were chosen as they allow people
to respond in their own words [49]. The patients were
asked the question “How did you experience answering
the questions that were asked before?” The question-
naire to the assessors consisted of the assessors’ experi-
ences of asking the questions in the 4AT, the patients’
reactions to answering the questions, using the 4AT
compared with not using a screening tool, and the ad-
vantages and disadvantages of using the 4AT as a rou-
tine procedure in clinical practice.
Data collection
After clinical consideration by Registered Nurses (RNs),
patients were included or excluded on the assessment
days. Patients who fulfilled the inclusion criteria received
oral and written information that described the aim and
content of the study. Informed oral consent was used as
patients with cognitive impairment might experience
discomfort when signing documents [50]. The consents
were obtained prior to the administration of the 4AT as-
sessment. In the cases where the patient was unable of
giving consent, the patient’s representative was consulted
about the consent. The oral consent was registered, as
well as whom who obtained the consent. The assess-
ments were conducted during daytime (09:00–16:00) to
avoid influence of the time of day on cognitive function.
Recruitment took place on selected assessment days
(Monday - Friday) from May 14, 2018, and continued
until 100 patients were included in each hospital, at the
university hospital in February 8, 2019 and at the county
hospital in September 4, 2018 (except for June 21–Au-
gust 20, 2018). At the university hospital, the 4AT as-
sessments were conducted by clinical RNs, clinical
physicians, and two of the authors (TT, NB) (n = 34) at
the same time as the 4AT was implemented in clinical
practice, while research nurses (n = 3) conducted the as-
sessments with the 4AT at the county hospital through-
out the study.
Data were collected through structured patient inter-
views and observations based on the instruments used in
the study, and from patient records. Additionally, the pa-
tients were asked about their experiences of answering
the questions in the 4AT before the OBS scale assess-
ment started. Finally, a questionnaire addressing the as-
sessors’ (n = 37) experiences of using the 4AT was
administered when data collection was completed, with
one reminder.
Before the study started, the assessors were pro-
vided with a brief basic introduction to delirium and
the 4AT, likewise new employees during the study
period. The 4AT was assessed simultaneously and in-
dependently by two assessors, to avoid any bias due
to the fluctuating nature of delirium. The target was
to perform the assessment with the OBS scale as
soon as possible after the assessment with the 4AT,
preferably within 30 min, taking into account the pa-
tient’s capacity and the level of exhaustion experi-
enced when responding to the questions about the
demographic variables and the 4AT. The time be-
tween the assessments with the 4AT and the OBS
scale measured in the county hospital (n = 100) was
in median 13 min 30 s (QL-QU 9:00–24:45) with
equal medium time for the patients with and without
dementia. All assessments were blinded, and the as-
sessors had no knowledge of the study test results.
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An overview of the informed consent and data collec-
tion in chronological order is shown in Table 1.
Data analyses
Descriptive statistics were calculated for all data. For as-
sociations between numerical variables of the ordinal
data type, Spearman’s correlation was used. Mann-
Whitney U-tests were used for comparisons between the
groups with respect to numerical variables, and the Chi-
square test was used for comparisons with respect to
categorical variables. In five patients, the assessments of
delirium with the 4AT did not yield a distinct and uni-
tary diagnosis. These data were handled as indeterminate
and removed from the diagnostic accuracy analysis, ex-
cept for the analysis of interrater reliability. A p-value of
0.05 (2-tailed) was considered statistically significant.
The 95% confidence interval was reported for the esti-
mates. All statistical analyses were carried out using the
SPSS Statistics software, Version 25.0 for Windows
(IBM Corp, Armonk, New York, USA).
Diagnostic accuracy
Comparison between the subscales in the 4AT and
the OBS scale Correlation between the scores in the
four subscales in the 4AT and the scores in the OBS
scale, and the items in the OBS scale part II, were calcu-
lated with Spearman’s correlation. As there is no cutoff
in the OBS scale, the data were divided into two groups
based on the dichotomized 4AT (4AT < 4 and ≥ 4) and
the corresponding scores of the OBS scale (part I, part II
and the total OBS scale). The differences between the
two groups were illustrated in a boxplot and calculated
using the Mann-Whitney U-test.
The index test accuracy versus the reference standard
After that all data had been collected in the study, the
delirium diagnosis was determined retrospectively by
four of the authors (YJ, TT, NB, EKS), two of whom are
physicians with their specialization in neuro-geriatric
medicine (TT, NB), and with long clinical experience of
using the DSM-IV-TR criteria. Blinded to the results of
the 4AT, the four authors independently evaluated the
results on the OBS scale and the patient records to de-
cide whether the patient met the DSM-IV-TR criteria
for delirium. A definitive diagnosis of delirium was
reached in consensus discussions.
In the comparison between the 4AT index test and the
DSM-IV-TR reference standard, the original cutoff ≥4
for delirium in the 4AT was used. The AUROC was cal-
culated, as well as the overall percentage agreement
(OPA), the sensitivity, specificity, and the positive (PPV)
and negative predictive values (NPV). To establish the
overall performance of the 4AT, Youden’s Index (J) was
calculated, where 0 = no value, and 1 = perfect test [51,
52]. These analyses were performed on the total sample
and the participating hospitals and wards, and on the
subgroups of patients with and without dementia.
Interrater reliability The Kappa coefficient of the
paired assessments of the 4AT was calculated. The
Kappa can be calculated if ≥ two paired assessments are
performed by two assessors, and if all categories in a test
are represented by each assessor. Interrater reliability
was calculated on the total sample as well as on the two
hospitals respectively.
Clinical applicability
Time duration Time durations for the assessments with
the 4AT and the OBS scale in the subsample (n = 100)
were calculated and reported as means. Differences be-
tween the time duration of the 4AT for patients with
and without delirium or dementia were calculated using
the Mann-Whitney U test.
Experiences of the 4AT The patients’ experiences of
being evaluated with the 4AT and the assessors’ re-
sponse of using the 4AT were separately analyzed with
manifest qualitative analysis according to Elo and Kyngäs
[53]. This analysis included open coding, the creation of
subcategories and generic categories based on similar-
ities and differences in the content. Codes, subcategories
and generic categories were continuously moved back
and forth and checked against the original text. Finally,
the number of patient and assessor experiences were
counted per category and the data were presented separ-
ately. The categories are reported in the text, and quotes
are used to further illuminate and validate the
categories.
Results
Demographic and clinical characteristics
There were 258 potentially eligible patients on assess-
ment days, 58 of whom were excluded (Fig. 1). In total,
200 patients were included in the study. Demographic
and clinical characteristics are presented in Table 2. Ac-
cording to the reference standard, delirium was present
in 36 of 200 patients (18, 95% CI = 13–24%), 21 at the
university hospital and 15 at the county hospital. The
highest prevalence of delirium occurred in the wards for
severe cognitive impairment (28%) and orthopedics
(19%). Patients with delirium were older, had a higher
prevalence of dementia, and 2 days longer hospital stays
than patients without delirium. According to the patient
records, 52 (26%) patients had dementia (37 patients in
the university hospital, 33 of whom were in the ward for
severe cognitive impairment, and 15 patients in the
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n = 164 (82%)
Delirium present
n = 36 (18%)
p value
Age, median (QL-QU)a 80 (73–87) 79 (73–85) 85 (78–88) 0.019d
Gender, n (%) 0.439e
Men 105 (53%) 84 (51%) 21 (58%)
Women 95 (48%) 80 (49%) 15 (42%)
Ward specialty, n (%) 0.023e
Severe cognitive impairment 67 (34%) 48 (29%) 19 (53%)
Geriatric stroke/neurology 17 (9%) 16 (10%) 1 (3%)
Geriatric multi-morbidity 16 (8%) 15 (9%) 1 (3%)
Orthopedics 67 (34%) 54 (33%) 13 (36%)
Urology 33 (17%) 31 (19%) 2 (6%)
Admission to ward, n (%) 0.436e
Acuteb 157 (79%) 127 (77%) 30 (83%)
Elective 43 (22%) 37 (23%) 6 (17%)
Length of hospital stay, median (QL-QU)a 9 (6–13) 8 (5–13) 10 (7.5–15) 0.011d
Dementia at dischargec n (%) 52 (26%) 37 (23%) 15 (42%) 0.018e
a QL-QU = Quartile, Lower – Quartile, Upper
b From Emergency Department (ED), other ward, other hospital or directly from own home
c As main diagnosis or comorbidity, with ICD-10 code or reported in record text
d Based on Mann-Whitney U-test (continuous variables)
e Based on (Pearson) Chi-Square test (categorical variables)
Fig. 1 STARD flow diagram (total across the two hospitals, n = 200)
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county hospital). Of those with dementia, 15 (29%) pa-
tients were diagnosed with delirium according to the ref-
erence standard (eight in the university hospital and
seven in the county hospital). In total, 73 (37%) patients
had dementia, delirium or a combination of both. In
addition, 16 (8%) patients displayed signs and symptoms
of mild cognitive impairment according to their records.
The most common main diagnoses were fracture related
to fall (n = 86/43%), delirium (n = 29/15%), and dementia
(n = 19/10%).
In the 4AT index test, where all items were completed
(n = 200), an indeterminate diagnosis occurred in five
(3%) patients due to differences in the scoring of atten-
tion/month backwards (n = 4), and/or acute changes or
fluctuating course (n = 3) in the paired assessments.
These five patients were removed from the analyses of
diagnostic accuracy, except for the analysis of interrater
reliability. In the remaining 195 patients, 33 patients
(17%, 95% CI = 12–23%), had delirium according to the
DSM-IV-TR reference standard criteria (18/95 in the
university hospital and 15/100 in the county hospital).
According to the 4AT index test, 36 of 195 patients
(19%) had delirium. Of the patients with delirium in the
4AT (n = 36), 23 had delirium, according to the refer-
ence standard; thus, the 4AT falsely detected 13 non-
delirious patients as delirious, according to the reference
standard. According to patient records, these patients
had dementia (n = 7), mild cognitive impairment (n = 4),
or brain tumor (n = 1). Additionally, one patient had de-
lirium as the main diagnosis. Moreover, the 4AT missed
ten patients with delirium according to the reference
standard. These were patients with dementia (n = 3),
mild cognitive impairment (n = 5), Lyme disease (1), or
delirium (n = 1), according to their records. Several of
these 23 patients also had other diseases that may have
affected the scoring, e.g., Parkinson’s disease, overcon-
sumption of alcohol, and previous TIA and stroke. Delir-
ium present, delirium absent or inconclusive are
presented in the flow chart (Fig. 1).
Of the 37 assessors, 14 (38%) responded to how they
experienced using the 4AT, 4 physicians and 10 RNs.
Twelve assessors worked in the university hospital, 6 of
whom in the general wards. The assessors had worked
1–38 years (mean 11.6) in their profession and 0.5–19
years (mean 8.7) in the current workplace.
Diagnostic accuracy
Comparison of the subscales in the 4AT and the OBS scale
The analysis of correlations between the scores in the
subscales in the 4AT and the subscales in the OBS scale
showed that there were positive correlations between the
4AT and the OBS scale, except with regard to neuro-
logical symptoms in part II of the OBS scale. Alertness
showed weak correlation with the OBS scale, but all pa-
tients except two were assessed as having normal alert-
ness (score 0). The two incorporated tests for cognitive
function had moderate to strong correlation with the
disorientation subscale, but also moderate correlation
with the confusion subscale and the items spatial
orientation-recognition, social interaction skills, and
language-speech difficulties. The item acute change
showed the strongest correlation with the confusion sub-
scale and the items delusions and hallucinations, emo-
tional reactions, and spatial orientation-recognition
(Table 3).
Boxplot distribution of the total score of the OBS scale
in the dichotomized 4AT (cutoff ≥4) (n = 200) is shown
in Fig. 2. The extreme values (n = 10) were seen in the
wards for severe cognitive impairment (n = 7), orthope-
dics (n = 2), and geriatric stroke/neurology (n = 1). They
Table 3 Correlations (Spearman’s coefficient) between the subscales in the 4AT and the subscales and items in the OBS scale (n =
200)
Instruments 4AT subscales
The OBS scale Alertness AMT-4 Months backwards Acute change
OBS total score 0.168a 0.766b 0.629b 0.317b
OBS part I (disorientation subscale) 0.171a 0.771b 0.616b 0.241a
OBS part II (confusion subscale) 0.164a 0.614b 0.525b 0.360b
Clinical state 0.187b 0.267b 0.279b 0.254b
Suspiciousness n.s. 0.312b 0.279b n.s.
Emotional reactions n.s. 0.375b 0.304b 0.292b
Language-speech difficulties 0.165a 0.577b 0.496b 0.239b
Delusions and hallucinations n.s. 0.217b 0.192b 0.354b
Neurological symptoms n.s. n.s. n.s. n.s.
Spatial orientation-recognition 0.196b 0.654b 0.528b 0.273b
Social interaction skills 0.180b 0.465b 0.522b 0.265b
asignificant at 0.05 level / bsignificant at 0.01 level
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consisted of patients with dementia (n = 4) or mild cog-
nitive impairment (n = 2) as the main diagnosis or co-
morbidity, or delirium (n = 4) as the main diagnosis in
their records. Seven of these ten patients also had other
diseases that may have affected the scoring on the OBS
scale, e.g., Parkinson’s disease, overconsumption of alco-
hol, memory problems, and previous TIA and stroke.
The comparison between the dichotomized 4AT and the
corresponding scores on the OBS scale, part I, part II
and the total OBS scale (Mann-Whitney U test, p = <
0.001), is reported in Table 4.
The index test accuracy versus the reference standard
With the cutoff ≥4, the AUROC for the total sample
(n = 195) was 0.808 (95% CI = 0.746–0.861). All esti-
mates were lower in the ward for severe cognitive im-
pairment compared with the other wards, whereas the
PPV was higher. In patients with dementia (n = 52), the
4AT was more sensitive and less specific. The Youden
index for the total sample was 0.617, with a higher index
in the general wards in both hospitals (0.695) (Table 5).
Interrater reliability
Each assessor in the university hospital (n = 34) con-
ducted 1–42 (Md 4) assessments with 4AT, and the as-
sessors in the county hospital (n = 3) 56–75 (Md 69)
assessments each. It was possible to calculate interrater
reliability with Kappa in 44 of the paired assessments in
the university hospital and in 100 in the county hospital
(n = 144). The strength of agreement between the asses-
sors was 0.918 (p < 0.001) overall (n = 144), 0.813 (p <
0.001) in the university hospital, and 0.969 (p < 0.001) in
the county hospital. In the 200 paired assessments with
4AT there was complete agreement in the alertness
score, while the attention score (Months backwards) dif-




The patients and the assessors in the county hospital
used 1–7 min (mean 2min 53 s) to complete the 4AT,
and 4min 30 s - 29 min (mean 12min 46 s) to complete
the OBS scale. The 4AT was completed in ≤2 min for
44% of the patients and ≤ 3 min for 74%. More time was
used to complete the 4AT for patients with delirium
(reference standard) (p = < 0.001), and for patients with
dementia (p = 0.023) (Mann-Whitney U test). Additional
time was also needed by the assessors to conduct a dia-
log with next of kin or care providers when a patient
had memory or communication difficulties, but that
time was not measured.
Patients’ experiences of being evaluated with the 4AT
Of the 200 patients, 180 (90%) responded to how they
experienced being evaluated with the 4AT. The
Table 4 Comparison between the dichotomized 4AT and the
corresponding scores on the OBS scale (n = 200)
4AT < 4p (n = 162) 4AT ≥ 4p (n = 38) p valuec
Median (QL-QUb) Median (QL-QUb)
OBS Total scorea 6 (3–14) 35 (24–48) < 0.001
OBS score part I 3 (0–9) 24 (12–29) < 0.001
OBS score part II 2 (0–5) 14 (8–20) < 0.001
a Total score = OBS scale part I + part II
b QL-QU = Quartile, Lower – Quartile, Upper
c Based on the Mann-Whitney U test
Fig. 2 Boxplot distribution of the OBS scale total score according to the dichotomized 4AT(cutoff ≥4) (n = 200)
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qualitative content analysis of their experiences resulted
in the following generic categories: (1) Easy and user-
friendly; (2) Associated with difficulties and concerns;
and (3) Challenging and demanding.
Of the 180 responding patients, a majority (n = 172)
experienced the 4AT to be easy and user-friendly. They
described the questions as being relevant, interesting,
and not unpleasant to answer. Some patients who had
expected more difficult questions, and questions requir-
ing pre-knowledge, thought that the 4AT was just a
warm-up. Even in the presence of memory problems,
the questions were not always experienced as being diffi-
cult to answer. A patient commented: “The questions
were not so difficult to answer, it was quite simple, but
you are not 25 years anymore … can’t remember”.
However, a few patients (n = 8) experienced the assess-
ment as being associated with difficulties and concerns.
They described the questions as being tough, boring, a
bit strange and difficult to answer. For example, they
were not used to answering questions about their
current location. One patient reflected on the benefit of
the questions in the 4AT “It was a little weird some-
times. Can’t imagine that it will be of any use, but I guess
it certainly can”.
Regardless of whether the 4AT and its questions were
considered easy and user-friendly or associated with dif-
ficulties and concerns, some patients (n = 15) experi-
enced the item Months Backwards as the most
challenging and demanding in the 4AT. Several of these
patients said that they had never performed the task be-
fore, and some had to stop counting and think instead.
One patient described performing this task as follows:
“It was harder than I thought it would be. I will practice
months backwards the rest of the week”.
Assessors’ experiences of using the 4AT
The qualitative content analysis of the 14 responding as-
sessors experiences of using the 4AT resulted in the fol-
lowing generic categories: (1) Easy and user-friendly in
daily practice; (2) Potential to improve patient care and
patient safety; (3) Evoked emotions in the patients; (4)
Evaluation challenges, and (5) Doubts about the useful-
ness and significance of the tool.
The 4 AT was experienced to be easy and user-
friendly in daily practice by the majority (n = 12) of the
responding assessors. It was experienced to be short, un-
complicated, and easy to use by all healthcare profes-
sionals without special training. The experience was that
most of the patients reacted positively to the test, they
participated and tried to respond as best they could
without major problems. However, for some patients the
assessment was challenging and took longer, especially
the Months Backwards test. Assessors thought that the
4AT was a good support tool that rapidly provided a
clear picture of the patient’s condition, and that it would
be easy to incorporate the 4AT in daily practice and
apply it to different care situations. The usefulness of the
4AT was expressed by one assessor as “Absolutely useful
as a routine test, and as a ‘must test’ for old people”.
According to the assessors who experienced the 4 AT
as easy and user-friendly (n = 12), the use of the 4AT
was experienced as affording the potential to improve
patient care and patient safety. The possibility of early
detection of delirium was described as enhancing and fa-
cilitating the provision of appropriate treatment and
support: “Assessment tools are an important part of data
collection that can provide better care and care planning
for older patients”. Predetermined questions, clear scor-
ing, and the fact that cognitive screening was incorpo-
rated in the 4AT were seen as advantages by the
assessors. Another described advantage was that the
4AT provided standardized mutual language and con-
cepts, which provided a more objective assessment than
subjective interpretations that the assessors believed to
be associated with a risk of undetected delirium: “When
the same assessment tool is used by everyone in the
personnel group and for all patients, the risk of misjudg-
ment is reduced”. In addition, assessors were of the opin-
ion that using the 4AT could increase the awareness of
delirium among professionals.
When the patients had difficulties responding, asses-
sors reported that the tool was experienced to evoke
various emotions in the patients (n = 9), such as irrita-
tion, frustration, anxiety, and anger. In some cases, when
a patient was unable to answer a question, the assessors
interpreted it as the patients feeling undervalued, stupid
and offended. Patients suffering from dementia or confu-
sion were identified as showing the strongest emotional
reactions. These reactions were thought to affect the as-
sessments: “Sometimes it (the assessment) has been diffi-
cult and sometimes OK. It depends on how the patient
reacts, because usually the patients become angry and
describe the questions as ridiculous”. The importance of
being able to adapt to the patient’s condition and reac-
tions and to act “in the right way” was highlighted.
Evaluation challenges were described in the use of the
4AT (n = 10). Assessors explained that some challenges
could be caused by the fact that they were unfamiliar
with the 4AT, e.g., that it was difficult to ask the ques-
tions in ways that the patient could understand and give
a response. The item acute changes was sometimes diffi-
cult for the patients to respond to, and there was not al-
ways a relative to ask. Assessors had observed that the
most demanding and troublesome item for the patients
was Months Backwards “Some items, for example, the
Months Backwards from December, was a little tricky for
many of the patients”. The assessors experienced that
the Months Backwards item took the longest time in the
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4AT and that it evoked emotional reactions. The most
challenging evaluation when using the 4AT was to assess
patients with severe dementia, severe confusion or lan-
guage difficulties, which one physician described as
“There were some non-Swedish patients who had difficul-
ties understanding, partly due to cognitive impairment
and partly due to language deficiencies”.
Some assessors (n = 5) expressed doubts about the use-
fulness and significance of the tool. They felt uncomfort-
able when they conducted the assessment. One assessor
experienced the assessment as an interrogation. For an-
other assessor (RN), it was unclear how the score of the
4AT was linked to nursing and nursing actions, but the
assessor still thought that the 4AT could be useful for
physicians: “As a nurse, I have not yet seen the connec-
tion to nursing and how different scores would lead to
different nursing actions”. Another assessor experienced
that the 4AT could not warn of delirium and that the
use of standardized screening tools is unnecessary if the
professionals have good clinical skills. The assessor
thought that it might be important for professionals with
less clinical experience to use the 4AT and for profes-
sionals who do not trust their own clinical skills. Regard-
ing the use of the 4AT in clinical practice, the
importance of information and education about the test
was highlighted: “Of course, it is important to inform and
educate about the 4AT, and to include all new
colleagues”.
Discussion
Our study showed that the Swedish version of the 4AT
is an accurate and applicable tool to use in clinical prac-
tice for detecting delirium in hospitalized patients across
different medical specialties. With a cutoff ≥4, the 4AT
showed good overall diagnostic performance, with 88%
overall agreement (OPA) in the total sample, and a
higher percentage in the general wards (91%). All esti-
mates of accuracy in the general wards were in line with
Shenkin et al. [33], who included patients from Emer-
gency rooms and acute geriatric wards.
The AUROC, which helps to estimate the discrimina-
tive power of a test, was 0.808 (95% CI = 0.746–0.861) in
the total sample, which is considered as very good [51].
In the subgroup patients with dementia, the 4AT was
more sensitive, and less specific, in line with Bellelli
et al. [32]. This could be expected, as it is known that
symptoms displayed by patients with dementia, espe-
cially severe dementia [54], may challenge the identifica-
tion of delirium due to significant clinical overlap [54–
56]. It is also known that measures of diagnostic accur-
acy are sensitive to the characteristics of the population,
such as the disease prevalence, the spectrum of the dis-
ease, and on the presence of concomitant health prob-
lems [51]. In this study, this is reflected by the false
positive (n = 13) and false negative (n = 10) outcomes on
the 4AT. Of those 23 patients, 10 hade dementia and 9
had mild cognitive impairment. Additionally, for patients
admitted to the special ward for severe cognitive impair-
ment the tool had lower diagnostic accuracy than for pa-
tients in the general wards, which might be explained by
the fact that most of the patients had moderate to severe
dementia, delirium, disorientation, or memory problems
in the special ward. Nevertheless, the AUROC was 0.759
(95% CI = 0.635–0.858) in the special ward for severe
cognitive impairment, which is considered to be good
[51]. As some time passed between the assessments with
the 4AT and the OBS scale (median 13 min 30 s), the
fluctuating course of delirium may have led to patients
displaying symptoms of delirium in one test but not in
the other. However, it might be valuable to evaluate the
4AT together with additional measures e.g. inattention
[54, 56, 57] in patients with severe cognitive impairment,
as delirium can be superimposed on dementia (DSD)
[54–57]. In addition, to evaluate 4 AT assessments car-
ried out by clinical professionals when implementing the
tool in clinical practice, as in the university hospital in
this study, could be valuable.
The total prevalence of delirium with the reference
standard was 18% but varied between the general wards
(13%) and the special ward for severe cognitive impair-
ment (28%). This was expected due to the differences
between the patients’ cause of admission, and the fact
that the prevalence of delirium differs by different diag-
noses and type of care [14] and, consequently, varies be-
tween different hospital wards [21, 58]. The prevalence
in the general wards in this study was in line with stud-
ies that have reported a prevalence of 12–15% in older
patients from a variety of medical specialties [5, 32, 33].
The choice of reference standard probably had less im-
pact on the diagnostic accuracy of our study. Of the few
delirium assessments tools available in Swedish, the OBS
scale was considered the most appropriate with the low-
est degree of subjective interpretation. Additionally, the
scale has been used to diagnose delirium in a number of
Swedish studies [6, 28, 48, 59]. The analyses of the sub-
scales in the 4AT and the subscales in the OBS scale
confirmed the expected correlations between the sub-
scales, which strengthens their concurrent validity. How-
ever, surprisingly, alertness in the 4AT showed the
lowest correlation with the OBS scale. It is known that
alertness is highly specific to delirium, and a very valu-
able sign clinically [32], but in our study, 198 of the 200
patients scored 0 (normal alertness, not agitated, to mild
sleepiness) on alertness, which may have affected the
overall diagnostic accuracy negatively. The fluctuating
course of delirium may have contributed to the scoring
outcome. Another contributing factor could be that the
assessment of alertness in the 4AT involves a degree of
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subjectivity, and that the binary scoring (0 or 4) tends to
result in a lower score than a more detailed reference
standard assessment [33], such as the OBS scale. Since
the cutoff for delirium in the 4AT is ≥4, it might hamper
the assessor from using the score of 4 (abnormal) if the
patient only displays mild abnormality, e.g., of agitation.
Additionally, lack of experience of assessing alertness or
insufficient information from reliable informants might
result in misjudgment of the patient’s alertness [60].
The item Months backward involves no subjective in-
terpretation. Nevertheless, it was the item that was the
most problematic. Ten of 200 paired assessments dif-
fered in scoring outcome, and several patients and asses-
sors perceived this item to be the most difficult for the
patients. According to the assessors, some patients—
above all those with dementia or delirium—became irri-
tated and frustrated when they had difficulties answering
the item. These emotional reactions may have affected
the assessors’ own attention negatively, with uncertainty
about how to handle the patient and the assessment. It
is obvious that special attention, knowledge, communi-
cation skills, and being able to adapt to the patient’s
condition and reactions are required. However, in the
Months backwards test it is not consistently defined
how to respond to a patient who is struggling with the
test, nor is the number of attempts allowed for best per-
formance stated [42]. Not surprisingly, our study showed
that it took longer to complete the total 4AT for partici-
pants with delirium and/or dementia. According to the
assessors, that was most obvious in the Months Back-
wards test. It has previously been shown that persons
with impaired cognitive function [25, 43, 61], above all
delirium [25, 62] have difficulties with the performance,
especially the backward speed. On the contrary, persons
with intact cognitive function can usually complete the
task in 15–20 s [42, 43, 61] up to 60–90 s [42]. Cutoff
times for the performance have been suggested [42, 43],
but are not included in the 4AT. To protect patient
comfort and dignity and reduce struggling and frustra-
tion, it may be appropriate to define the number of at-
tempts allowed in the 4AT, in combination with time
limits in line with the suggestions by Meagher et al. [42].
This may reduce the simplicity of the tool but likely fa-
cilitate the assessment situation.
Despite the difficulties described, the strength of
agreement in the paired assessments of the 4AT was >
0.8 in the two hospitals. This is demonstrating that the
4AT is reliable for use by different professionals and
levels of seniority, as measured in the university hospital.
Most patients, and most of the responding assessors,
perceived no problems with the 4AT assessment. Asses-
sors believed that the tool could easily be incorporated
in daily routines and that it might improve patient out-
comes. However, a few assessors expressed doubts about
the tool’s usefulness in clinical practice. One assessor’s
opinion reflected an over-reliance on his/her own sub-
jective clinical judgment, which has been identified as a
cause of unidentified cases of delirium in hospitals [23,
63]. The doubts may reflect a lack of familiarity with
using assessment tools, especially for cognitive impair-
ment as in delirium. Even if the 4AT is easy to use by
any professional, basic knowledge about delirium and
delirium care is needed for an understanding of the ben-
efits of the assessment. The results are similar to those
of MacLullich et al. [38], who highlighted the need for
increased knowledge about delirium in general and the
4AT in particular. Important is an understanding of
which actions are appropriate based on the scoring out-
come in the 4AT, e.g., collaboration between medical
and nursing professionals, and a more detailed assess-
ment of delirium when the 4AT indicates delirium [38].
Some limitations have to be acknowledged. The most
appropriate reference standard assessment, considered the
gold standard for the delirium diagnosis, is bedside inter-
views by physicians using the DSM criteria [64]. However,
no physician was available for such a time-consuming as-
sessment and the OBS scale has been used extensively in
Swedish research [28]. Several patients with severe cogni-
tive impairment were excluded, which may have led to an
underestimation of the delirium rates. Another limitation
was that dementia and mild cognitive impairment were
not assessed bedside, as these conditions might be under-
reported in patient records [65]. A strength of the study
was the evaluation of accuracy as well as applicability
using quantitative and qualitative methods, which is sel-
dom conducted when a test is evaluated. The perspectives
from statistical analyses, and the patients’ as well as the
healthcare professionals’ experiences of using the 4AT
gave a deeper understanding of using the tool. In addition,
it provided useful and valuable knowledge for the imple-
menting process of the 4AT in clinical practice. For the
analysis of interrater reliability, we used a large sample of
assessors (n = 144). As geriatric patients have a wide range
of diseases and conditions, we evaluated the 4AT in differ-
ent medical specialties, regardless of the patient’s diagno-
sis or the cause of the delirium. Therefore, patients with
diverse medical conditions were included from two hospi-
tals in different geographical regions, from surgical and
non-surgical specialties. The inclusion of patients from a
special ward for severe cognitive impairment could be a
strength but also a limitation, as the sample became rather
diverse. Therefore, in the analysis of accuracy, data were
analyzed for the total sample and separately for the differ-
ent wards.
Conclusion
Our study indicates that the Swedish version of the 4AT
possesses diagnostic accuracy to be used as an
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assessment tool for delirium detection in older hospital-
ized patients in a variety of medical specialties. Further-
more, the 4AT is an applicable screening tool for use in
clinical practice by different professionals and levels of
seniority. It is well tolerated by patients, easy to use for
healthcare professionals, and only takes a few minutes to
perform. However, the assessor must be particularly ob-
servant and focused to ensure correct scoring, especially
as the 4AT may evoke emotions if a patient struggles
with the test. In conclusion, to improve patient care, pa-
tient safety, and patient outcomes, we recommend that
the 4AT could be incorporated in the daily routine in
clinical practice in healthcare settings in Sweden. More-
over, use of the 4AT as a routine delirium assessment
test opens possibilities to use the clinical data in inter-
national environments. Future research should address
predisposing risk factors for delirium for early identifica-
tion, particularly in vulnerable patients who thus might
be targeted for preventative interventions.
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